Drug Metabolism and Pharmacokinetics, CNSP iMed Science (J.B.), and Safety Assessment (A.A., D.H., S.B., H.A., A.S.), AstraZeneca R&D, Innovative Medicines, Södertälje, Sweden; and Department of Pharmaceutical Biosciences, Uppsala Biomedical Centre, Uppsala University, Uppsala, Sweden (J.B.)

Drug Metabolism and Pharmacokinetics, CNSP iMed Science (J.B.), and Safety Assessment (A.A., D.H., S.B., H.A., A.S.), AstraZeneca R&D, Innovative Medicines, Södertälje, Sweden; and Department of Pharmaceutical Biosciences, Uppsala Biomedical Centre, Uppsala University, Uppsala, Sweden (J.B.)

Drug Metabolism and Pharmacokinetics, CNSP iMed Science (J.B.), and Safety Assessment (A.A., D.H., S.B., H.A., A.S.), AstraZeneca R&D, Innovative Medicines, Södertälje, Sweden; and Department of Pharmaceutical Biosciences, Uppsala Biomedical Centre, Uppsala University, Uppsala, Sweden (J.B.)

Drug Metabolism and Pharmacokinetics, CNSP iMed Science (J.B.), and Safety Assessment (A.A., D.H., S.B., H.A., A.S.), AstraZeneca R&D, Innovative Medicines, Södertälje, Sweden; and Department of Pharmaceutical Biosciences, Uppsala Biomedical Centre, Uppsala University, Uppsala, Sweden (J.B.)

Drug Metabolism and Pharmacokinetics, CNSP iMed Science (J.B.), and Safety Assessment (A.A., D.H., S.B., H.A., A.S.), AstraZeneca R&D, Innovative Medicines, Södertälje, Sweden; and Department of Pharmaceutical Biosciences, Uppsala Biomedical Centre, Uppsala University, Uppsala, Sweden (J.B.)

Drug Metabolism and Pharmacokinetics, CNSP iMed Science (J.B.), and Safety Assessment (A.A., D.H., S.B., H.A., A.S.), AstraZeneca R&D, Innovative Medicines, Södertälje, Sweden; and Department of Pharmaceutical Biosciences, Uppsala Biomedical Centre, Uppsala University, Uppsala, Sweden (J.B.)